NCT07138417 Compassion-Based Family Intervention for Adolescents
| NCT ID | NCT07138417 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Beijing HuiLongGuan Hospital |
| Condition | Emotional Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2025-08-30 |
| Primary Completion | 2027-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2025-08-30 with a primary completion date of 2027-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Adolescents with emotional disorders often experience psychological distress that may also affect their parents, creating bidirectional stress within the family. This randomized waitlist-controlled trial will evaluate a 6-week compassion-based family intervention involving adolescents and their parents. A total of 60 parent-adolescent dyads will be randomly assigned to either an intervention group or a waitlist control group. The primary outcomes are adolescents' depressive and anxiety symptoms. Secondary outcomes include broader psychological and family-related measures. Parent-child neural and physiological synchrony will also be explored using fNIRS hyperscanning and wearable devices. Assessments will be conducted at baseline, post-intervention, and 3-month and 6-month follow-ups.
Eligibility Criteria
Inclusion Criteria: * the adolescent is aged 12-18 years * for the adolescent, required scores at enrollment: at least one of the following criteria is met (i) 17-item Hamilton Depression Rating Scale (HAMD-17) (Hamilton, 1960) total score ≥17 and ≤30, (ii) Hamilton Anxiety Rating Scale (HAMA) (Hamilton, 1959) total score ≥18 and ≤29; and in addition, the HAMD-17 item 3 (suicide) score must be ≤ 2 * at least one parent is willing to participate * the adolescent has normal auditory and visual perception abilities and intellectual functioning * the participating parent has normal reading and writing ability * the adolescent has no history of manic episodes Exclusion Criteria: * the adolescent presents with psychotic symptoms, bipolar disorder, or schizophrenia * the parent suffers from a mental illness or psychological disorder * the adolescent or their parent has a history of substance abuse * the adolescent or their parent has a severe neurological disorder or major physical disease * the adolescent or their parent is assessed as having high suicide risk
Contact & Investigator
Dongmei Wang, Ph.D
PRINCIPAL INVESTIGATOR
Institute of Psychology, Chinese Academy of Sciences
Frequently Asked Questions
Who can join the NCT07138417 clinical trial?
This trial is open to participants of all sexes, aged 12 Years or older, up to 18 Years, studying Emotional Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07138417 currently recruiting?
Yes, NCT07138417 is actively recruiting participants. Contact the research team at wangdm@psych.ac.cn for enrollment information.
Where is the NCT07138417 trial being conducted?
This trial is being conducted at Hefei, China.
Who is sponsoring the NCT07138417 clinical trial?
NCT07138417 is sponsored by Beijing HuiLongGuan Hospital. The principal investigator is Dongmei Wang, Ph.D at Institute of Psychology, Chinese Academy of Sciences. The trial plans to enroll 60 participants.